Today, the federal Food and Drug Administration (FDA) approved the first GIP/GLP-1 called “Zepbound” for the purpose of weight loss. The drug is manufactured by Eli Lily and contains tirzepatide, the same active ingredient already present in an existing medication called Mounjaro. The State Health Plan (SHP) added Mounjaro to its approved list of pharmaceuticals for the purpose of treating diabetes effective Jan. 1, 2024.
I was sorry to hear the news that State Auditor Beth Wood will not seek reelection in 2024. She has been a valuable colleague and public servant. She always keeps the best interests of the taxpayers in her heart and mind. I look forward to working with her during the remainder of her term. I’m sure she will finish strong.
Dr. Combs dedicated her life to public service at the local, state and federal levels, receiving five executive appointments under three presidents including Controller of the U.S. Office of Management and Budget, and Chief Financial Officer of the Department of Treasury, Environmental Protection Agency and Department of Transportation.
The Department of State Treasurer is committed to encouraging individuals to prioritize, plan and stay motivated as they move toward retirement, and its efforts have been recognized with a prestigious award.
It happens far too often that someone on the verge of retirement realizes the consequences of not saving enough. This year, we asked the Legislature to consider a $25 monthly match for state employees.